ReviewJournal of the Society for Cardiovascular Angiography & Interventions2026
Evaluation and Treatment of Myocardial Bridging by Clinical Phenotype.
Review in Journal of the Society for Cardiovascular Angiography & Interventions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Myocardial bridging (MB), most commonly involving the left anterior descending artery, is an intramyocardial segment of a coronary artery traditionally regarded as a benign anatomical variant. However, in a subset of patients, MB has been implicated in anginal syndromes, myocardial infarction, and even sudden cardiac death. Most cases are asymptomatic and identified incidentally on coronary computed tomography or invasive angiography. Controversy surrounds best practices for management of this entity. This review summarizes current evidence in adult patients with isolated MB on the mechanisms producing ischemia and adverse cardiac outcomes, the value of testing modalities to diagnose ischemia, and treatment strategies based on the patient's symptoms and clinical presentation (phenotype).
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.